Based in Germany, Dreamfold is a startup founded in 2019. Brouky records 1 investor associated with the company.
Dreamfold develops a generative protein design platform that applies machine learning to design safer, more effective antibody and protein therapeutics, with early wet‑lab validation aimed at reducing toxicity and improving efficacy in challenging diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.